Junliang Zhao, Yuanwei Li, Xinyang Cai, Diwei Zhao, Jun Wang, Xingbo Long et al. Neoadjuvant Hormonal Therapy Before Radical Prostatectomy: Favorable Pathological and PSA Outcomes Do Not Guarantee Favorable Oncological Outcomes. // Prostate. – 2026. – DOI: 10.1002/pros.70250. – URL: https://onlinelibrary.wiley.com/doi/10.1002/pros.70250?af=R
Junliang Zhao, Yuanwei Li, Xinyang Cai, Diwei Zhao, Jun Wang, Xingbo Long, Yijun Zhang, Yun Cao, Dong Chen, Fangjian Zhou, Zhenyu Yang, & Yonghong Li (2026). Neoadjuvant Hormonal Therapy Before Radical Prostatectomy: Favorable Pathological and PSA Outcomes Do Not Guarantee Favorable Oncological Outcomes. Prostate. https://doi.org/10.1002/pros.70250
Junliang Zhao, et al. “Neoadjuvant Hormonal Therapy Before Radical Prostatectomy: Favorable Pathological and PSA Outcomes Do Not Guarantee Favorable Oncological Outcomes.” Prostate, 2026. doi:10.1002/pros.70250.
@article{Zhao2026,
title = {Neoadjuvant Hormonal Therapy Before Radical Prostatectomy: Favorable Pathological and PSA Outcomes Do Not Guarantee Favorable Oncological Outcomes},
author = {Zhao, Junliang and Li, Yuanwei and Cai, Xinyang and Zhao, Diwei and Wang, Jun and Long, Xingbo and Zhang, Yijun and Cao, Yun and Chen, Dong and Zhou, Fangjian and Yang, Zhenyu and Li, Yonghong},
journal = {Prostate},
year = {2026},
doi = {10.1002/pros.70250},
url = {https://onlinelibrary.wiley.com/doi/10.1002/pros.70250?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...